JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 7, 2008; DOI: 10.1124/jpet.107.132803


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.132803v1
325/1/154    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brighton, P. J
Right arrow Articles by Willars, G. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brighton, P. J
Right arrow Articles by Willars, G. B
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH


Received for publication October 16, 2007.
Revised January 4, 2008.
Accepted for publication January 4, 2008.

Paradoxical behaviour of neuromedin U in isolated smooth muscle cells and intact tissue

Paul J Brighton 1, Narinder B Dass 2, Alan Wise 2, Gary B Willars 1*

1 University of Leicester 2 GlaxoSmithKline

* Address correspondence to: E-mail: gbw2{at}le.ac.uk

Abstract

Neuromedin U (NmU) is a neuropeptide showing high levels of structural conservation across different species. Since its discovery in 1985, NmU has been implicated in numerous physiological roles including smooth muscle contraction, energy homeostasis, stress, intestinal ion transport, pro-nociception and circardian rhythm. Two GPCRs have been identified for NmU and cloned from humans, rats and mice. Recombinantly expressed NmU receptors couple to both G{alpha}q/11 and G{alpha}i G-proteins, whilst NmU binds essentially irreversibly, preventing signaling to repetitive applications of NmU. It is unclear, however, whether these properties reflect those of endogenously expressed NmU receptors or how these properties influence the functional consequences of NmU receptor signaling. Here we have explored the signaling by rat NmU receptors expressed endogenously in cultured rat colonic smooth muscle cells, and explore the functional consequence of this signaling by investigating the NmU-mediated contraction of ex-vivo rat colonic smooth muscle preparations. We demonstrate that endogenous rat NmU receptors couple to both G{alpha}q/11 and G{alpha}i G-proteins. Further, we show complex patterns of Ca2+ signaling, including oscillations and provide evidence of essentially irreversible binding of NmU to smooth muscle cells. Challenge of either circular or longitudinal rat isolated colonic smooth muscle preparations with NmU resulted in robust contractions. Stimulation was direct and paradoxically, repetitive applications of NmU mediated repetitive contractions with no evidence of desensitisation, highlighting a major discrepancy between NmU binding in single-cells and in intact tissues. The reason for this discrepancy is presently unknown.


Key words: GPCR, binding, calcium, neuromedin U, regulation, smooth muscle





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.